Clinical and genomic characterization of ERBB2-altered gallbladder cancer.

被引：0
|
作者：
Mondaca, Sebastian
Schultz, Nikolaus
Roa, Juan Carlos
Walch, Henry S.
Sepulveda, Santiago
Harding, James J.
Yaqubie, Amin
Garcia, Patricia
Aguayo, Gloria
Nervi, Bruno
Li, Bob T.
Abou-Alfa, Ghassan K.
机构：
[1] Pontificia Univ Catolica Chile, Dept Hematol & Oncol, Fac Med, Santiago, Chile
[2] Pontificia Univ Catolica Chile, Fac Med, Dept Pathol, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Santiago, Chile
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[5] Pontificia Univ Catolica Chile, Dept Pathol, Santiago, Chile
[6] Hosp Dr Sotero del Rio, Dept Pathol, Santiago, Chile
[7] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA
[8] Cornell Univ, Weill Med Coll, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4114
引用
收藏
页数：1
相关论文
共 50 条
  • [31] COMPLETE - Study the ErbB2 (HER2) - positive Breast cancer.
    Arnheim, Katharina
    Aktas, Bahriye
    ONKOLOGIE, 2010, 33 (04):
  • [32] Clinical and morphological characterization for detection of hypermutation in colorectal cancer.
    Shimada, Yoshifumi
    Tajima, Yosuke
    Nagahashi, Masayuki
    Ichikawa, Hiroshi
    Yuza, Kizuki
    Miura, Kohei
    Tanaka, Kana
    Ando, Takuya
    Soma, Daiki
    Hirose, Yuki
    Tsuchida, Junko
    Nakano, Masato
    Kameyama, Hitoshi
    Sakata, Jun
    Kobayashi, Takashi
    Takii, Yasumasa
    Lyle, Stephen
    Okuda, Shujiro
    Takabe, Kazuaki
    Wakai, Toshifumi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Clinical and molecular characterization of fusion genes in colorectal cancer.
    Karan, Canan
    Tan, Elaine
    Sarfraz, Humaira
    Walko, Christine Marie
    Kim, Richard D.
    Knepper, Todd C.
    Sahin, Ibrahim Halil
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15568 - E15568
  • [34] Reciprocal regulation of NOTCH1 and ErbB2 in breast cancer.
    Osipo, C.
    Patel, P.
    Lupu, R.
    Miele, L.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S245 - S246
  • [35] Tissue and serum expression of c-erbB-2 protein in breast cancer.
    Covello, M
    Labriola, A
    Venneri, MT
    Italia, A
    Zito, A
    Marzullo, F
    Quaranta, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 618 - 618
  • [36] Serum ErbB-2 as a sensitive marker for monitoring recurrent breast cancer.
    Kitoh, T
    Sugano, K
    Ushiama, M
    Fukutomi, F
    Tsuda, H
    Ohkura, H
    CLINICAL CHEMISTRY, 1999, 45 (06) : A110 - A111
  • [37] Patient-derived organoids as a potential tool for clinical decision in advanced gallbladder cancer.
    Obreque, Javiera
    Vergara, Luis
    Suarez, Felipe
    Garcia, Patricia
    Marcelain, Katherine
    Toro, Jessica
    Rivas, Solange
    Rosa, Lorena
    Carlos Roa, Juan
    Nervi, Bruno
    Vinuela, Eduardo
    Aguayo, Gloria
    Muniz-Munoz, Sabrina
    Caire, Nicole
    Escalante, Anrried
    Mondaca, Sebastian
    Bizama, Carolina
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Altered expression of β-catenin and c-erbB-2 in early gastric cancer
    Ougolkov, A
    Mai, M
    Takahashi, Y
    Omote, K
    Bilim, V
    Shimizu, A
    Minamoto, T
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2000, 19 (03): : 349 - 355
  • [39] Molecular Classification and Tumor Microenvironment Characterization of Gallbladder Cancer by Comprehensive Genomic and Transcriptomic Analysis
    Ebata, Nobutaka
    Fujita, Masashi
    Sasagawa, Shota
    Maejima, Kazuhiro
    Okawa, Yuki
    Hatanaka, Yutaka
    Mitsuhashi, Tomoko
    Oosawa-Tatsuguchi, Ayako
    Tanaka, Hiroko
    Miyano, Satoru
    Nakamura, Toru
    Hirano, Satoshi
    Nakagawa, Hidewaki
    CANCERS, 2021, 13 (04) : 1 - 18
  • [40] Clinical and molecular immune characterization of ERBB2 in glioma
    Mei, Jie
    Wang, Tiejun
    Xu, Rui
    Chen, Daozhen
    Zhang, Yan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 94
12345